(3R,6S)-5-(tert-Butoxycarbonyl)-1,1-difluoro-5-azaspiro[2.4]heptane-6-carboxylic acid
97%
- Product Code: 36764
CAS:
1430105-52-4
| Molecular Weight: | 277.26 g./mol | Molecular Formula: | C₁₂H₁₇F₂NO₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28556951 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of complex organic molecules, particularly in the development of active pharmaceutical ingredients (APIs). Its unique spirocyclic structure and functional groups make it valuable for constructing biologically active compounds, especially those targeting neurological and metabolic disorders. The tert-butoxycarbonyl (Boc) protecting group allows for selective reactions during multi-step synthesis, while the difluoro and carboxylic acid groups enhance the molecule's reactivity and potential for further derivatization. It is often employed in medicinal chemistry research to explore new drug candidates with improved efficacy and safety profiles.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.025 | 10-20 days | ฿7,155.00 |
+
-
|
(3R,6S)-5-(tert-Butoxycarbonyl)-1,1-difluoro-5-azaspiro[2.4]heptane-6-carboxylic acid
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of complex organic molecules, particularly in the development of active pharmaceutical ingredients (APIs). Its unique spirocyclic structure and functional groups make it valuable for constructing biologically active compounds, especially those targeting neurological and metabolic disorders. The tert-butoxycarbonyl (Boc) protecting group allows for selective reactions during multi-step synthesis, while the difluoro and carboxylic acid groups enhance the molecule's reactivity and potential for further derivatization. It is often employed in medicinal chemistry research to explore new drug candidates with improved efficacy and safety profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :